Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.

Taking on the challenge of treating sarcomas

Sarcomas are hard to understand and treat, and outcomes for patients remain poor. Cancers of unmet need like sarcomas are a major focus for our scientists, who are working to open up fresh avenues for research and treatment.
Treating sarcomas
Race equality: How the ICR is going beyond the statements

One year ago the ICR made commitments to tackling racial inequality. We spoke to some of the people involved in our progress and discussed the challenges ahead.
Race equality
The gift of giving: how your generosity can lead to change

As we thank generous donors to our Spring fundraising appeal, our Director of Development Lara Jukes reflects on why giving is an integral part of our culture and how much of a difference it can make to those who need it most.
The gift of giving
Sign-ups for the Terry Fox Run UK are open!

Run with us in Battersea Park on 2 October 2021, or run, walk or cycle in your local area any distance to help us transform the future of cancer treatment. Let’s finish cancer together.
Find out more

1/4

Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Our innovative approaches
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Big data research
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Personalised treatments
Queen's Anniversary Prize

The ICR has been recognised with a prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Queen's Anniversary Prize
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours.
About drug discovery
Making it count

We will deliver better outcomes and quality of life for patients by establishing innovative treatments, diagnostics and prevention strategies as part of routine healthcare.
Improving patient lives